SABCS 2024: New Research Assesses iCAD’s Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations
icad inc. (ICAD)
Last icad inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
icadmed.com/financial-news-and-events.html
Company Research
Source: GlobeNewswire
NASHUA, N.H., Dec. 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, announced today that four novel AI-driven breast cancer research abstracts have been accepted for presentation at the 2024 San Antonio Breast Cancer Symposium (SABCS), taking place from December 10-13, 2024. These clinical abstracts highlight the latest research in breast health AI, focusing on improving detection and risk prediction accuracy and assessing disparities across diverse populations. Presenting Author Chirag R. Parghi, MD, MBA, Chief Medical Officer at Solis Mammography, will showcase three research abstracts during Poster Session 2, scheduled for Wednesday, December 11, 2024, from 5:30 to 7:00 p.m. CST. Additional contributing authors include Jennifer Pantleo, R.N., BSN; Julie Shisler, BS; Jeff Hoffmeister, M.D., MSEE; Zi Zhang, M.D., M.P.H; Avi Sharma, M.D.; and, Wei Zhang, PhD. Additionally, p
Show less
Read more
Impact Snapshot
Event Time:
ICAD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICAD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICAD alerts
High impacting icad inc. news events
Weekly update
A roundup of the hottest topics
ICAD
News
- SABCS 2024: New Research Assesses iCAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations [Yahoo! Finance]Yahoo! Finance
- CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024GlobeNewswire
- iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024 [Yahoo! Finance]Yahoo! Finance
- iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024GlobeNewswire
- iCAD, Inc. (NASDAQ: ICAD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
ICAD
Sec Filings
- 11/14/24 - Form 10-Q
- 11/13/24 - Form 8-K
- ICAD's page on the SEC website